Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (191-200 of 401) with videos related to

Pageof 41
Sort By:
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Journal of the American Heart Association|October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) TrialPontus Andell, Stefan K James, Christopher P Cannon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2025
Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary SyndromesThomas Andersen, Thor Ueland, Tatevik Ghukasyan Lakic, et al.
Clinical Cardiology|October 10, 2019
Interleukin-18 in patients with acute coronary syndromesAxel Åkerblom, Stefan K James, Tatevik G Lakic, et al.
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
Platelets|May 23, 2025
Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrelMark A Sammut, Mohammed E F Rahman, Claire Bridge, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
JACC. Basic to Translational Science|September 19, 2017
The IL-1RI Co-Receptor TILRR (<i>FREM1</i> Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular DiseaseSarah A Smith, Andriy O Samokhin, Mabruka Alfadi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 3, 2022
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbentRitu Tripathi, Jesus Morales, Victoria Lee, et al.
Clinical Chemistry and Laboratory Medicine|February 11, 2024
Temporal biomarker concentration patterns during the early course of acute coronary syndromeKai M Eggers, Gorav Batra, Bertil Lindahl, et al.
Pageof 41

Showing results (191-200 of 401) with videos related to

Sort By:
Pageof 41
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Journal of the American Heart Association|October 11, 2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) TrialPontus Andell, Stefan K James, Christopher P Cannon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 25, 2025
Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary SyndromesThomas Andersen, Thor Ueland, Tatevik Ghukasyan Lakic, et al.
Clinical Cardiology|October 10, 2019
Interleukin-18 in patients with acute coronary syndromesAxel Åkerblom, Stefan K James, Tatevik G Lakic, et al.
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
Platelets|May 23, 2025
Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrelMark A Sammut, Mohammed E F Rahman, Claire Bridge, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
JACC. Basic to Translational Science|September 19, 2017
The IL-1RI Co-Receptor TILRR (<i>FREM1</i> Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular DiseaseSarah A Smith, Andriy O Samokhin, Mabruka Alfadi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 3, 2022
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbentRitu Tripathi, Jesus Morales, Victoria Lee, et al.
Clinical Chemistry and Laboratory Medicine|February 11, 2024
Temporal biomarker concentration patterns during the early course of acute coronary syndromeKai M Eggers, Gorav Batra, Bertil Lindahl, et al.
Pageof 41